Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,982.40
(
0.43%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.35
(
0.74%
)
Bitcoin
76,728.36
(
1.10%
)
News Focus
News Focus
Post# of 16503
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 19
Posts 6171
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: Easka post# 10876

Friday, 04/17/2020 8:02:21 PM

Friday, April 17, 2020 8:02:21 PM

Post# of 16503
Easka. The orphan drug exclusivity expired .


Patents and Proprietary Rights

The FDA first approved the use of Acthar in 1952, and Acthar is no longer subject to patent protection. Acthar does have orphan drug exclusivity for its infantile spasm indication that extends until October 15, 2017 for that indication only

.

https://www.sec.gov/Archives/edgar/data/891288/000119312514264708/d755101dex991.htm
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ANIP News
More ANIP News